Login
Home
Charts
Search
Watchlist
Products

Systematix Corporate Services Ltd

SYSTMTXC·BSE
79.00+1.61%Thu, 24 Sept '26

Systematix Corporate Services Ltd

SYSTMTXC
BSE
79.00
+1.61%
|Thu, 24 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,079Cr
Close
Close Price
79.00
Industry
Industry
Finance & Investments - Others
PE
Price To Earnings
PS
Price To Sales
6.38
Revenue
Revenue
169Cr
Rev Gr TTM
Revenue Growth TTM
14.44%
PAT Gr TTM
PAT Growth TTM
-102.77%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
204853293742303956342456
Growth YoY
Revenue Growth YoY%
69.5120.6245.866.082.3-12.0-44.533.852.0-20.5-20.743.6
Expenses
ExpensesCr
171728262921282435303359
Operating Profit
Operating ProfitCr
331263822116214-10-2
OPM
OPM%
17.164.548.49.921.951.04.939.737.011.4-40.6-4.0
Other Income
Other IncomeCr
0151215401013
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
001111111122
PBT
PBTCr
2312922724414191-12-3
Tax
TaxCr
176156035102
PAT
PATCr
2242322219310141-12-5
Growth YoY
PAT Growth YoY%
121.9307.74,241.1-60.71,130.0-22.4-85.8501.1-34.6-96.3-457.3-146.8
NPM
NPM%
8.949.843.55.960.444.011.126.726.02.0-50.2-8.7
EPS
EPS
0.11.81.80.11.71.40.20.81.10.1-0.9-0.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
204853293742303956342456
Growth YoY
Revenue Growth YoY%
69.5120.6245.866.082.3-12.0-44.533.852.0-20.5-20.743.6
Expenses
ExpensesCr
171728262921282435303359
Operating Profit
Operating ProfitCr
331263822116214-10-2
OPM
OPM%
17.164.548.49.921.951.04.939.737.011.4-40.6-4.0
Other Income
Other IncomeCr
0151215401013
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
001111111122
PBT
PBTCr
2312922724414191-12-3
Tax
TaxCr
176156035102
PAT
PATCr
2242322219310141-12-5
Growth YoY
PAT Growth YoY%
121.9307.74,241.1-60.71,130.0-22.4-85.8501.1-34.6-96.3-457.3-146.8
NPM
NPM%
8.949.843.55.960.444.011.126.726.02.0-50.2-8.7
EPS
EPS
0.11.81.80.11.71.40.20.81.10.1-0.9-0.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3238505651558973137139146169
Growth
Revenue Growth%
0.420.030.913.4-8.56.962.8-18.889.01.74.914.4
Expenses
ExpensesCr
222437414350636973104115156
Operating Profit
Operating ProfitCr
91313159526364353113
OPM
OPM%
29.935.426.227.216.98.829.04.846.625.121.27.5
Other Income
Other IncomeCr
4662212692914
Interest Expense
Interest ExpenseCr
1213913104333445
Depreciation
DepreciationCr
111661112356
PBT
PBTCr
-169-3-512366857236
Tax
TaxCr
02300061141197
PAT
PATCr
-146-3-41185534614-2
Growth
PAT Growth%
-176.3540.161.6-145.8-51.9129.61,229.2-71.0949.6-14.2-69.8-102.8
NPM
NPM%
-2.910.412.9-5.2-8.72.419.67.038.932.89.5-0.9
EPS
EPS
-0.10.30.5-0.2-0.30.11.40.44.13.51.0-0.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3238505651558973137139146169
Growth
Revenue Growth%
0.420.030.913.4-8.56.962.8-18.889.01.74.914.4
Expenses
ExpensesCr
222437414350636973104115156
Operating Profit
Operating ProfitCr
91313159526364353113
OPM
OPM%
29.935.426.227.216.98.829.04.846.625.121.27.5
Other Income
Other IncomeCr
4662212692914
Interest Expense
Interest ExpenseCr
1213913104333445
Depreciation
DepreciationCr
111661112356
PBT
PBTCr
-169-3-512366857236
Tax
TaxCr
02300061141197
PAT
PATCr
-146-3-41185534614-2
Growth
PAT Growth%
-176.3540.161.6-145.8-51.9129.61,229.2-71.0949.6-14.2-69.8-102.8
NPM
NPM%
-2.910.412.9-5.2-8.72.419.67.038.932.89.5-0.9
EPS
EPS
-0.10.30.5-0.2-0.30.11.40.44.13.51.0-0.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1313131313131313131414
Reserves
ReservesCr
3943496762648286139286300
Current Liabilities
Current LiabilitiesCr
12514214998365810074143118
Non Current Liabilities
Non Current LiabilitiesCr
32132626363081310
Total Liabilities
Total LiabilitiesCr
207226249204138171225181308428435
Current Assets
Current AssetsCr
1712052317282121155113234351
Non Current Assets
Non Current AssetsCr
362118132565071687477
Total Assets
Total AssetsCr
207226249204138171225181308428435
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1313131313131313131414
Reserves
ReservesCr
3943496762648286139286300
Current Liabilities
Current LiabilitiesCr
12514214998365810074143118
Non Current Liabilities
Non Current LiabilitiesCr
32132626363081310
Total Liabilities
Total LiabilitiesCr
207226249204138171225181308428435
Current Assets
Current AssetsCr
1712052317282121155113234351
Non Current Assets
Non Current AssetsCr
362118132565071687477
Total Assets
Total AssetsCr
207226249204138171225181308428435

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
55-3-1649931851-1588-20-8
Investing Cash Flow
Investing Cash FlowCr
1111-1-2-1542411-17
Financing Cash Flow
Financing Cash FlowCr
-47811-55-836-9-14-398-6
Net Cash Flow
Net Cash FlowCr
96-5-4102227-2510889-31
Free Cash Flow
Free Cash FlowCr
54-4-1749921850-1675-23
CFO To PAT
CFO To PAT%
-6,115.2-85.7-248.2-1,688.1-2,098.11,355.2289.1-303.3164.6-44.0-58.2
CFO To EBITDA
CFO To EBITDA%
584.0-25.3-122.1323.61,074.1371.3195.2-446.6137.5-57.6-25.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
55-3-1649931851-1588-20-8
Investing Cash Flow
Investing Cash FlowCr
1111-1-2-1542411-17
Financing Cash Flow
Financing Cash FlowCr
-47811-55-836-9-14-398-6
Net Cash Flow
Net Cash FlowCr
96-5-4102227-2510889-31
Free Cash Flow
Free Cash FlowCr
54-4-1749921850-1675-23
CFO To PAT
CFO To PAT%
-6,115.2-85.7-248.2-1,688.1-2,098.11,355.2289.1-303.3164.6-44.0-58.2
CFO To EBITDA
CFO To EBITDA%
584.0-25.3-122.1323.61,074.1371.3195.2-446.6137.5-57.6-25.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
23223358551935312821,0121,9167371,079
Price To Earnings
Price To Earnings
5.65.2147.530.555.819.142.153.2
Price To Sales
Price To Sales
0.70.50.61.01.13.55.93.87.011.45.06.4
Price To Book
Price To Book
0.50.40.50.70.72.55.62.96.76.42.43.4
EV To EBITDA
EV To EBITDA
9.56.69.67.94.334.018.168.313.447.816.965.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
OPM
OPM%
29.935.426.227.216.98.829.04.846.625.121.27.5
NPM
NPM%
-2.910.412.9-5.2-8.72.419.67.038.932.89.5-0.9
ROCE
ROCE%
7.511.09.56.15.04.121.47.641.019.18.28.2
ROE
ROE%
-1.77.010.2-3.7-5.91.718.45.135.015.34.44.4
ROA
ROA%
-0.41.82.6-1.4-3.20.87.82.817.310.73.23.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
23223358551935312821,0121,9167371,079
Price To Earnings
Price To Earnings
5.65.2147.530.555.819.142.153.2
Price To Sales
Price To Sales
0.70.50.61.01.13.55.93.87.011.45.06.4
Price To Book
Price To Book
0.50.40.50.70.72.55.62.96.76.42.43.4
EV To EBITDA
EV To EBITDA
9.56.69.67.94.334.018.168.313.447.816.965.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
OPM
OPM%
29.935.426.227.216.98.829.04.846.625.121.27.5
NPM
NPM%
-2.910.412.9-5.2-8.72.419.67.038.932.89.5-0.9
ROCE
ROCE%
7.511.09.56.15.04.121.47.641.019.18.28.2
ROE
ROE%
-1.77.010.2-3.7-5.91.718.45.135.015.34.44.4
ROA
ROA%
-0.41.82.6-1.4-3.20.87.82.817.310.73.23.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Systematix Corporate Services is a full-service Indian financial firm built to be a one-stop shop for a client’s entire financial lifecycle, from raising growth capital to managing personal wealth. Founded in 1985 by Mr. Chandra Prakash Khandelwal and listed on the BSE and NSE, the group has spent four decades assembling a hub-and-spoke model where a central merchant bank feeds and is fed by a network of broking, wealth, and asset management subsidiaries. The recurring approach is to use deep, mid-market investment banking relationships as the anchor, then cross-sell execution, advisory, and financing services to the same companies and their promoters as they grow. # Business segments Three engines that feed each other - a mid-market investment bank that creates the relationships, an institutional equities platform that executes the trades, and a newly built private wealth and asset management arm that gathers the assets - each one fuelling the next. ## 1. Merchant banking: the relationship engine that creates the fees **A SEBI-registered Category I merchant banker that earns one-time, transaction-linked fees by advising mid-sized Indian companies on raising capital, going public, or selling stakes - the group’s original business and the source of its corporate relationships.** - **Paid per deal, not per hour** - the division earns fee-based income from advisory mandates and equity capital market transactions, with revenue recognised only when a transaction’s specific obligations are fulfilled, making income lumpy but directly tied to successful deal closures. - **A mid-market specialist** - it positions itself as a go-to advisor for medium-sized companies, helping them raise growth capital, execute IPOs, and advising promoters and private equity funds on stake sales, with a team of 30+ professionals whose 12-member advisory core carries a cumulative 120 years of experience. - **The deal roster is the credential** - over the last six years, the firm has executed more than ₹35,000 crore in investment banking transactions, including ₹4,000 crore in private equity and M&A deals, and in FY25 alone closed 28 transactions raising over ₹15,400 crore, capturing a 7.5% market share of all QIP (Qualified Institutional Placement) issuance in India that year. - **Sector-agnostic, relationship-driven** - the team has handled deals across hospitality, automobiles, pharmaceuticals, logistics, green energy, and more than a dozen other sectors, with marquee transactions including a ₹3,500 crore fundraise for Bank of Maharashtra and a ₹3,320 crore QIP for Swan Energy. ## 2. Institutional equities and brokerage: the execution engine that monetises the flow **A commission-based trading desk that executes equity, derivative, commodity, and currency trades for over 40,000 clients and 200+ institutional investors, supported by in-house research covering roughly 328 stocks - turning market access into a recurring revenue stream.** - **Institutional reach is the moat** - the firm is empanelled with more than 200 institutional investors and has a direct sales team covering 95 foreign funds across Singapore, Hong Kong, the UAE, the UK, and the US, plus 145 domestic institutions including HDFC Mutual Fund, ICICI Prudential, and Goldman Sachs. - **Research as the hook** - a dedicated team produces incisive, objective research across 20+ sectors and 328 stocks, with a particular knack for identifying ‘Hidden Gems’ in the small and mid-cap space, which feeds both institutional trading ideas and the wealth management team’s portfolio construction. - **A franchisee network for retail reach** - the firm reaches mass retail and affluent clients through a 62+ franchisee network spread across more than 100 cities, including Mumbai, Delhi, Kolkata, and Ahmedabad, giving it a pan-India distribution footprint without owning every branch. - **The annual conference is the showcase** - its flagship investor conference, “Manthan,” brings together 80+ companies, 400+ clients, and 200+ funds, generating over 3,000 meeting requests and featuring corporates like LIC, Sun Pharma, and Vedanta, which deepens institutional relationships and feeds the deal pipeline. ## 3. Private wealth and asset management: the asset-gathering engine built on top **A newly scaled platform that earns recurring, AUM-based fees by managing money for wealthy individuals and families through portfolio management services (PMS) and alternative investment funds (AIFs), while distributing third-party financial products - the group’s bet on sticky, long-duration capital.** - **Built, not just bought** - the private wealth business was officially launched in FY26, led by senior bankers with 27+ and 26+ years of experience at firms like Axis Bank, Barclays Private Bank, and Standard Chartered, and already holds AUM and custody assets of roughly ₹7,800 crore. - **A new suite of funds for growth-stage companies** - the group has launched a Category I AIF (the India SME Growth Fund, ₹125 crore) targeting high-growth small and medium enterprises, and a Category II AIF (the India Equity Opportunities Fund, ₹1,000 crore) for mid and late-stage companies seeking growth capital, with a real estate fund scheduled to follow. - **Client-centric, not product-push** - the wealth management approach tailors services to each client’s specific requirements, drawing on an in-house research team that spans equities, derivatives, fixed income, currencies, and mutual funds, so the advice is built on proprietary insight rather than third-party sales scripts. # Group structure and partners **A hub-and-spoke architecture where the listed parent company holds the merchant banking licence and five wholly-owned subsidiaries run the regulated operating businesses - broking, financing, and wealth - each with its own SEBI or RBI registration.** - **The parent is the merchant banker** - Systematix Corporate Services Ltd itself holds the SEBI Category I Merchant Banker registration and operates the investment banking division, while also acting as the listed entity on the BSE and NSE. - **Broking sits in a separate subsidiary** - Systematix Shares and Stocks (India) Limited holds memberships of the BSE, NSE, MCX, and NCDEX, and is also a CDSL depository participant, portfolio manager, research analyst, and AMFI-registered mutual fund distributor, making it the group’s primary execution and advisory vehicle. - **Financing runs through two RBI-registered NBFCs** - Systematix Fincorp India Limited and Systematix Finvest Private Limited conduct the group’s lending activities, primarily loans against shares and margin funding, with credit risk managed through upfront margins and real-time position monitoring. - **Wealth and asset management is being consolidated** - Systematix Ventures Private Limited (proposed to be rebranded as Systematix Wealth Private Ltd) is the dedicated vehicle for alternative investment funds, wealth management, and distribution, with the board having approved the transfer of the wealth and PMS business into this entity to create a focused wealth company.

Documents — Systematix Corporate Services Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/enojxp6hq8siqh7mzcjt5tjq.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/c06qithoziz3l45fb5whcwzn.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/b9cdmj7vochfek0t99iwbp6f.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/64ogkas2d61ycrz6kwm8fhzu.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/4k8kxuvedkfn701444gq6ef7.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/mq0n39q7g78ueh67x426z66g.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/o0iizj6k7t9wcwfc52e4vliy.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/c76essvuqdy70swt5n5fhfcj.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/lcsqk4xrxqe4i7drv8j7w5zu.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/jjvhrpc3272l7tzx0goqgi3g.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/7wbgkx2lu82wfxqxp1317adl.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/efuhblr9cb3si3tlqgi3gi9s.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/77no42r6ntg97bamdr9v3g8w.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/cnrbhmagztf7fh3m0jtnuqxe.pdf
  • Q1 FY2025 Investor Presentation (Jun 2024, PDF): https://www.stockscans.in/document/9aison2puqcpd5zphuula0fo.pdf
  • Q4 FY2024 Investor Presentation (Mar 2024, PDF): https://www.stockscans.in/document/4z1a4k4j5i63zb8ot96i6kmj.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/9tzegi9kyc8b5s5493jkhwao.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/trp7ydtzi9qoc884ml3m243v.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/ngqb8inv595pzg65moxro7tx.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/7i3l1m6n1aqj7r572hs7zrmj.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/ctboiwl9kaucev0vov8bs5qq.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/oga0xh1zpyzwhrwofuvn4uug.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/2qpqd6losfbixwklwo8z8ev2.pdf